Active Series A Biotech Investors (2026)

Raising capital in the Biotech space requires finding partners who understand your specific market dynamics. The investors listed here are actively deploying capital and looking for high-growth opportunities with defensible competitive advantages. Series A investors are focused on scaling. They expect proven business models, strong unit economics, and a clear path to dominating a market segment.

Sector: Biotech Stage: Series A + Geography + Check size

Lisheng Wang

Biotech · $250K-$3M

TSVC is a seed-stage venture capital firm founded in 2010 that identifies forward-thinking entrepreneurs

Active now

MM

Mark Martin

Biotech · $60K–$500K

Cybernetix Ventures invests in pre-seed, seed, and Series A robotics, automation, and industrial AI startups across manufacturing, logistics...

Active now

RW

Rob Wilder

Biotech

FTW Ventures is an early-stage venture fund focused on food and agricultural technology that deploys capital to support founders solving sys...

Active now

FT

Finian Tan

Biotech

Vickers Venture Partners, founded by Dr. Finian Tan in 2005, invests in early-stage deep-tech companies and life sciences ventures globally...

Active now

Avijeet Alagathi, CFA

Biotech · $500K–$3,000K

Shastra VC is an early-stage venture fund backing science- and engineering-led companies in deeptech, artificial intelligence, climate techn...

Active now

Jason McBride

Biotech · $750K–$3,000K

AIX Ventures, where Jason McBride is a Partner, invests exclusively in AI-native companies where artificial intelligence serves as the core...

Active now

JD

Jack Dreifuss

Biotech

Impatient Ventures is a pre-Series A fund that backs mission-driven founders with relentless drive and clarity of vision. The fund focuses o...

Active now

Kevin Crowley

Biotech

Kevin Crowley leads Connecticut Innovations' venture debt and equity investment portfolio, focusing on closely held and venture-backed compa...

Active now

RC

Rowan Chapman

Biotech · $500K-$3M

BEVC partners with entrepreneurs on their unique journeys to create, scale, and exit meaningful biotech and tech ventures. The fund invests...

Active now

MK

Maha Katabi

Biotech

Maha Katabi is a General Partner at Sofinnova Investments focused on development-stage biopharmaceuticals with over two decades of experienc...

Active now

Tom Williams

Biotech · Up to $250K pre-investment threshold

Tom Williams founded Heron Rock Capital as an exclusively first-check investor platform backing exceptional founders and difficult ideas bef...

Active now

Related

Get matched free